Dr. Katie Paul Friedman serves as Director for the Center for Chemical Informatics and Screening within the Chemical Insights Research Institute of UL Research Institutes. Previously, Dr. Paul Friedman worked in the Office of Research and Development at the US Environmental Protection Agency, most recently as Acting Director for the Biomolecular and Computational Toxicology Division in the Center for Computational Toxicology and Exposure. Her broad computational research portfolio demonstrates application of new approach methods to chemical safety assessment and building confidence in those methods. Dr. Paul Friedman has led strategic research initiatives such as New Chemicals Collaborative Research Program, the ToxCast bioactivity screening program, and Toxicity Reference Database. Dr. Paul Friedman brings experience as a regulatory toxicologist from her time at Bayer. She has been active in multi-stakeholder projects to develop alternatives and their acceptance, including through technical leadership at federal advisory committees and international research efforts. Her laboratory background includes development of high-throughput screening assays and combined use of in vitro and in vivo approaches. Dr. Paul Friedman received a Ph.D. in Toxicology from the University of North Carolina at Chapel Hill and has authored > 75 peer-reviewed publications and mentored > 18 early career trainees.